These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31172789)

  • 21. [Modulation of the beta-adrenergic system during acute myocardial infarction: rationale for a new clinical trial].
    Ibáñez B; Fuster V; Macaya C; Jiménez-Borreguero J; Iñiguez A; Fernández-Ortiz A; Sanz G; Sánchez-Brunete V
    Rev Esp Cardiol; 2011 Jul; 64 Suppl 2():28-33. PubMed ID: 21807284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis kinetics at reperfusion period in patients with acute ST-Segment Elevation Myocardial Infarction undergoing primary percutaneous coronary intervention and treated with thrombolytic therapy.
    Gultekin N; Bulut G; Kucukates E; Yildiz A; Kocas C; Bulut L
    J Pak Med Assoc; 2016 Jul; 66(7):808-14. PubMed ID: 27427127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphine and myocardial ischaemia-reperfusion.
    Wu LN; Hu R; Yu JM
    Eur J Pharmacol; 2021 Jan; 891():173683. PubMed ID: 33121952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarction.
    Hortmann M; Robinson S; Mohr M; Mauler M; Stallmann D; Reinöhl J; Duerschmied D; Peter K; Carr J; Gibson CM; Bode C; Ahrens I
    Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):695-702. PubMed ID: 28534645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanistic Role of mPTP in Ischemia-Reperfusion Injury.
    Morciano G; Bonora M; Campo G; Aquila G; Rizzo P; Giorgi C; Wieckowski MR; Pinton P
    Adv Exp Med Biol; 2017; 982():169-189. PubMed ID: 28551787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implications of ventricular arrhythmia "bursts" with normal epicardial flow, myocardial blush, and ST-segment recovery in anterior ST-elevation myocardial infarction reperfusion: a biosignature of direct myocellular injury "downstream of downstream".
    Majidi M; Kosinski AS; Al-Khatib SM; Smolders L; Cristea E; Lansky AJ; Stone GW; Mehran R; Gibbons RJ; Crijns HJ; Wellens HJ; Gorgels AP; Krucoff MW
    Eur Heart J Acute Cardiovasc Care; 2015 Feb; 4(1):51-9. PubMed ID: 25063574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PCI in patients with ST-elevation myocardial infarction trial.
    Roolvink V; Rasoul S; Ottervanger JP; Dambrink JH; Lipsic E; van der Horst IC; de Smet B; Kedhi E; Marcel Gosselink AT; Piek JJ; Sanchez-Brunete V; Ibanez B; Fuster V; Van't Hof AW;
    Am Heart J; 2014 Nov; 168(5):661-6. PubMed ID: 25440793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.
    Lønborg J; Vejlstrup N; Kelbæk H; Bøtker HE; Kim WY; Mathiasen AB; Jørgensen E; Helqvist S; Saunamäki K; Clemmensen P; Holmvang L; Thuesen L; Krusell LR; Jensen JS; Køber L; Treiman M; Holst JJ; Engstrøm T
    Eur Heart J; 2012 Jun; 33(12):1491-9. PubMed ID: 21920963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model.
    Ichimura K; Matoba T; Nakano K; Tokutome M; Honda K; Koga J; Egashira K
    PLoS One; 2016; 11(9):e0162425. PubMed ID: 27603665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.
    Roolvink V; Ibáñez B; Ottervanger JP; Pizarro G; van Royen N; Mateos A; Dambrink JE; Escalera N; Lipsic E; Albarran A; Fernández-Ortiz A; Fernández-Avilés F; Goicolea J; Botas J; Remkes W; Hernandez-Jaras V; Kedhi E; Zamorano JL; Navarro F; Alfonso F; García-Lledó A; Alonso J; van Leeuwen M; Nijveldt R; Postma S; Kolkman E; Gosselink M; de Smet B; Rasoul S; Piek JJ; Fuster V; van 't Hof AWJ;
    J Am Coll Cardiol; 2016 Jun; 67(23):2705-2715. PubMed ID: 27050189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel therapeutics in myocardial infarction: targeting microvascular dysfunction and reperfusion injury.
    Fordyce CB; Gersh BJ; Stone GW; Granger CB
    Trends Pharmacol Sci; 2015 Sep; 36(9):605-16. PubMed ID: 26148636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of preinfarction angina and coronary collateral blood flow on the efficacy of remote ischaemic conditioning in patients with ST segment elevation myocardial infarction: post hoc subgroup analysis of a randomised controlled trial.
    Pryds K; Bøttcher M; Sloth AD; Munk K; Rahbek Schmidt M; Bøtker HE;
    BMJ Open; 2016 Nov; 6(11):e013314. PubMed ID: 27884851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reperfusion in STEMI patients: still a role for cardioprotection?
    Ottani F; Limbruno U; Latini R; Misuraca L; Galvani M
    Minerva Cardioangiol; 2018 Aug; 66(4):452-463. PubMed ID: 29589674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardioprotection for percutaneous coronary intervention--reperfusion quality as well as quantity.
    Giblett JP; West NE; Hoole SP
    Int J Cardiol; 2014 Dec; 177(3):786-93. PubMed ID: 25453404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
    de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
    Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving myocardial injury, infarct size, and myocardial salvage in the era of primary PCI for STEMI.
    Ndrepepa G
    Coron Artery Dis; 2015 Jun; 26(4):341-55. PubMed ID: 25715338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preconditioning and postconditioning: underlying mechanisms and clinical application.
    Hausenloy DJ; Yellon DM
    Atherosclerosis; 2009 Jun; 204(2):334-41. PubMed ID: 19081095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial.
    Janssens SP; Bogaert J; Zalewski J; Toth A; Adriaenssens T; Belmans A; Bennett J; Claus P; Desmet W; Dubois C; Goetschalckx K; Sinnaeve P; Vandenberghe K; Vermeersch P; Lux A; Szelid Z; Durak M; Lech P; Zmudka K; Pokreisz P; Vranckx P; Merkely B; Bloch KD; Van de Werf F;
    Eur Heart J; 2018 Aug; 39(29):2717-2725. PubMed ID: 29800130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postconditioning reduces enzymatic infarct size and improves microvascular reperfusion in patients with ST-segment elevation myocardial infarction.
    Araszkiewicz A; Grygier M; Pyda M; Rajewska J; Michalak M; Lesiak M; Grajek S
    Cardiology; 2014; 129(4):250-7. PubMed ID: 25402666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction?
    Allencherril J; Alam M; Levine G; Jneid H; Atar D; Kloner RA; Birnbaum Y
    J Cardiovasc Pharmacol Ther; 2019 May; 24(3):215-224. PubMed ID: 30563349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.